Results 91 to 100 of about 667,007 (283)

Western Blotting

open access: yesBIO-PROTOCOL, 2022
Kamal Gandhi   +5 more
  +4 more sources

Summary of antibodies used for western blotting.

open access: yes, 2014
Summary of antibodies used for western blotting.
Keith Moore (513271)   +3 more
core   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Western Blotting Minimal Reporting Standard (WBMRS).

open access: yes, 2015
Western Blotting Minimal Reporting Standard (WBMRS).
Sue C. Bodine (784901)   +5 more
core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Antibodies used for Immunohistochemistry and Western Blotting.

open access: yes, 2014
Antibodies used for Immunohistochemistry and Western Blotting.
Maria Elisabetta Maragnoli (613942)   +5 more
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Can we use 2,3,5-Triphenyltetrazolium chloride-stained brain slices for other purposes? the application of western blotting [PDF]

open access: yes, 2019
2,3,5-Triphenyltetrazolium chloride (TTC) staining is a commonly used method to determine the volume of the cerebral infarction in experimental stroke models.
Ong, Lin Kooi   +4 more
core   +1 more source

N122-419 is immunoreactive in Western blotting.

open access: yes, 2022
N122-419 was subjected to SDS-PAGE, transferred to nitrocellulose membrane and to Western blotting using positive (A), and negative sera (B) for SARS-CoV-2.
Matheus Martins Di Lela (12042726)   +7 more
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy